ELVN
Price
$45.11
Change
-$0.98 (-2.13%)
Updated
Sep 24, 03:03 PM (EDT)
Capitalization
3.38B
55 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$12.30
Change
-$0.60 (-4.65%)
Updated
Sep 24, 12:01 PM (EDT)
Capitalization
1.14B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELVN vs MLTX

ELVN vs MLTX Comparison Chart in %
View a ticker or compare two or three
VS
ELVN vs. MLTX commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Buy and MLTX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ELVN vs MLTX: Fundamental Ratings
ELVN
MLTX
OUTLOOK RATING
1..100
5415
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4187
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5043

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLTX's Valuation (24) in the null industry is in the same range as ELVN (33). This means that MLTX’s stock grew similarly to ELVN’s over the last 12 months.

MLTX's Profit vs Risk Rating (95) in the null industry is in the same range as ELVN (100). This means that MLTX’s stock grew similarly to ELVN’s over the last 12 months.

ELVN's SMR Rating (94) in the null industry is in the same range as MLTX (98). This means that ELVN’s stock grew similarly to MLTX’s over the last 12 months.

ELVN's Price Growth Rating (41) in the null industry is somewhat better than the same rating for MLTX (87). This means that ELVN’s stock grew somewhat faster than MLTX’s over the last 12 months.

ELVN's P/E Growth Rating (100) in the null industry is in the same range as MLTX (100). This means that ELVN’s stock grew similarly to MLTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELVNMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 14 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (ELVN: $46.09 vs. MLTX: $12.90)
Brand notoriety: ELVN and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 146% vs. MLTX: 157%
Market capitalization -- ELVN: $3.38B vs. MLTX: $1.1B
ELVN [@Biotechnology] is valued at $3.38B. MLTX’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.87B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 1 FA rating(s) are green while MLTX’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • ELVN’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а -6.17% price change this week, while MLTX (@Biotechnology) price change was +3.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.48%. For the same industry, the average monthly price growth was -11.14%, and the average quarterly price growth was +7.50%.

Reported Earning Dates

ELVN is expected to report earnings on Nov 18, 2026.

MLTX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-2.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ELVN
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOGZ0.940.04
+4.42%
Dogness (International) Corp
PCAR112.09-1.81
-1.59%
PACCAR
OVBC43.61-1.59
-3.52%
Ohio Valley Banc Corp
HELP13.02-0.69
-5.03%
Cybin Inc
EWTX41.05-3.46
-7.77%
Edgewise Therapeutics

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-3.59%
KALA - MLTX
82%
Closely correlated
-5.26%
XNCR - MLTX
50%
Loosely correlated
-3.58%
NRIX - MLTX
45%
Loosely correlated
-6.97%
AUPH - MLTX
45%
Loosely correlated
-1.62%
XENE - MLTX
44%
Loosely correlated
-6.47%
More